Hepatitis C treatments don't seem to work as well in African Americans

July 2004

Hepatitis C treatments don't seem to work as well in African Americans...as in other racial and ethnic groups.

Peginterferon alfa-2b (PEG-Intron) and ribavirin (Rebetol) is effective in 52% of whites...but only 19% of African Americans.

Researchers used to think the difference was due to the type of hepatitis C virus that's more common in African Americans...but now researchers are rethinking this theory.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote